|
Refueling
for a longer race
Managers are trying hard to extend the life of their existing
products to maintain the revenue streams for their companies,
thereby making life cycle management an important issue in
the pharma industry, Nandini Patwardhan discovers
‘Old
barriers will break down’
Vikas Vats, Director, Marketing, of the US-based MarketRx
talks to Nandini Patwardhan about the various business models
that have emerged in the pharma industry
TRIPs
plus—choice or compulsion?
India has sincerely attempted to go the extra mile to meet
with the TRIPS compliance. Was it worth it? Will the TRIPs
plus regime benefit India? Gopakumar Nair takes a look
Assault
by Brazil and India on IPR continues
Defenders of Property Rights (DPR) announced that it has sent
an open letter to the US Trade Representative, Rob Portman,
urging the US Government to block efforts by Brazil and India
from undermining the World Trade Organization, as their campaign
against IPR continues. DPR believes their actions against
IPR undermine the strength of the American economy.
Regulating
the CRO space
Coined the next best thing to IT revolution, CRO boom is providing
high hopes of commerce and employment. But what is that makes
India the perfect CRO destination? Is it the patient pool
or the cost advantage or it is the regulations? Industry leaders
talk to Katya Naidu about regulations for conducting clinical
trials in India
The
doc is in!
Katya Naidu takes a look at the yet to be launched state-of-the-art
pain management device by HCL
Unlocking
Business Intelligence
Companies are now turning to Business Intelligence and analytics
to get the power to identify and deliver more valuable drug
leads quickly and consistently. George Varghese explains
|
